218 related articles for article (PubMed ID: 23874958)
1. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.
Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC
PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958
[TBL] [Abstract][Full Text] [Related]
2. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
[TBL] [Abstract][Full Text] [Related]
3. Intracellular calprotectin (S100A8/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma.
Argyris PP; Saavedra F; Malz C; Stone IA; Wei Y; Boyle WS; Johnstone KF; Khammanivong A; Herzberg MC
Oral Oncol; 2023 Feb; 137():106304. PubMed ID: 36608459
[TBL] [Abstract][Full Text] [Related]
4. S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells.
Silva EJ; Argyris PP; Zou X; Ross KF; Herzberg MC
Int J Biochem Cell Biol; 2014 Oct; 55():279-87. PubMed ID: 25236491
[TBL] [Abstract][Full Text] [Related]
5. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
[TBL] [Abstract][Full Text] [Related]
6. Intracellular calprotectin (S100A8/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma.
Argyris PP; Slama Z; Malz C; Koutlas IG; Pakzad B; Patel K; Kademani D; Khammanivong A; Herzberg MC
Oral Oncol; 2019 Aug; 95():1-10. PubMed ID: 31345374
[TBL] [Abstract][Full Text] [Related]
7. S100A8/A9 stimulates keratinocyte proliferation in the development of squamous cell carcinoma of the skin via the receptor for advanced glycation-end products.
Iotzova-Weiss G; Dziunycz PJ; Freiberger SN; Läuchli S; Hafner J; Vogl T; French LE; Hofbauer GF
PLoS One; 2015; 10(3):e0120971. PubMed ID: 25811984
[TBL] [Abstract][Full Text] [Related]
8. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
9. IL-1 receptor regulates S100A8/A9-dependent keratinocyte resistance to bacterial invasion.
Sorenson BS; Khammanivong A; Guenther BD; Ross KF; Herzberg MC
Mucosal Immunol; 2012 Jan; 5(1):66-75. PubMed ID: 22031183
[TBL] [Abstract][Full Text] [Related]
10. Interaction between S100A8/A9 and annexin A6 is involved in the calcium-induced cell surface exposition of S100A8/A9.
Bode G; Lüken A; Kerkhoff C; Roth J; Ludwig S; Nacken W
J Biol Chem; 2008 Nov; 283(46):31776-84. PubMed ID: 18786929
[TBL] [Abstract][Full Text] [Related]
11. Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo.
Grebhardt S; Müller-Decker K; Bestvater F; Hershfinkel M; Mayer D
J Cell Physiol; 2014 May; 229(5):661-71. PubMed ID: 24122301
[TBL] [Abstract][Full Text] [Related]
12. S100A8 and S100A9 in inflammation and cancer.
Gebhardt C; Németh J; Angel P; Hess J
Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
[TBL] [Abstract][Full Text] [Related]
13. Neuroplastin-β mediates S100A8/A9-induced lung cancer disseminative progression.
Sumardika IW; Chen Y; Tomonobu N; Kinoshita R; Ruma IMW; Sato H; Kondo E; Inoue Y; Yamauchi A; Murata H; Yamamoto KI; Tomida S; Shien K; Yamamoto H; Soh J; Futami J; Putranto EW; Hibino T; Nishibori M; Toyooka S; Sakaguchi M
Mol Carcinog; 2019 Jun; 58(6):980-995. PubMed ID: 30720226
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase D inhibitor CRT0066101 suppresses bladder cancer growth in vitro and xenografts via blockade of the cell cycle at G2/M.
Li QQ; Hsu I; Sanford T; Railkar R; Balaji N; Sourbier C; Vocke C; Balaji KC; Agarwal PK
Cell Mol Life Sci; 2018 Mar; 75(5):939-963. PubMed ID: 29071385
[TBL] [Abstract][Full Text] [Related]
15. S100A8/A9 Induced by Interaction with Macrophages in Esophageal Squamous Cell Carcinoma Promotes the Migration and Invasion of Cancer Cells via Akt and p38 MAPK Pathways.
Tanigawa K; Tsukamoto S; Koma YI; Kitamura Y; Urakami S; Shimizu M; Fujikawa M; Kodama T; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Am J Pathol; 2022 Mar; 192(3):536-552. PubMed ID: 34954212
[TBL] [Abstract][Full Text] [Related]
16. β-1,3-Galactosyl-
Sumardika IW; Youyi C; Kondo E; Inoue Y; Ruma IMW; Murata H; Kinoshita R; Yamamoto KI; Tomida S; Shien K; Sato H; Yamauchi A; Futami J; Putranto EW; Hibino T; Toyooka S; Nishibori M; Sakaguchi M
Oncol Res; 2018 Apr; 26(3):431-444. PubMed ID: 28923134
[TBL] [Abstract][Full Text] [Related]
17. Expression of S100A8/A9 in HaCaT keratinocytes alters the rate of cell proliferation and differentiation.
Voss A; Bode G; Sopalla C; Benedyk M; Varga G; Böhm M; Nacken W; Kerkhoff C
FEBS Lett; 2011 Jan; 585(2):440-6. PubMed ID: 21192933
[TBL] [Abstract][Full Text] [Related]
18. Fast IMAC purification of non-tagged S100A8/A9 (calprotectin) from Homo sapiens and Sus scrofa.
Hau JL; Kremser H; Knogl-Tritschler S; Stefanski V; Steuber J; Fritz G
Protein Expr Purif; 2023 Aug; 208-209():106275. PubMed ID: 37084837
[TBL] [Abstract][Full Text] [Related]
19. S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis.
Ghavami S; Chitayat S; Hashemi M; Eshraghi M; Chazin WJ; Halayko AJ; Kerkhoff C
Eur J Pharmacol; 2009 Dec; 625(1-3):73-83. PubMed ID: 19835859
[TBL] [Abstract][Full Text] [Related]
20. S100A8/A9 promotes parenchymal damage and renal fibrosis in obstructive nephropathy.
Tammaro A; Florquin S; Brok M; Claessen N; Butter LM; Teske GJD; de Boer OJ; Vogl T; Leemans JC; Dessing MC
Clin Exp Immunol; 2018 Sep; 193(3):361-375. PubMed ID: 29746703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
